Abstracts - faqs.org

Abstracts

Health

Search abstracts:
Abstracts » Health

Mechanisms of glove tears and sharp injuries among surgical personnel

Article Abstract:

It is necessary to develop methods for reducing the risk of transmitting human immunodeficiency virus (HIV) and other blood-borne pathogens to health care workers. (HIV is the causative agent of AIDS.) Operating room personnel have a high risk of contact with contaminated blood. A surgeon's cumulative life-time risk of seroconversion (evidence of antibody response to the presence of HIV) has been estimated to be as high as 1 to 10 percent. In order to design preventive strategies, a better understanding is needed of how exposure occurs. A study was undertaken to classify the mechanisms of glove tears and injuries resulting from sharp objects as they occur in the operating room. Over a three-month period at a large teaching hospital, all glove tears and sharp injuries occurring in the operating room were reviewed. The injured person was interviewed immediately after the incident by a nurse. During 2,292 operations, 249 glove tears and 70 injuries from sharp objects were documented. In 63 percent of the glove tears, there was visible contact with the patient's blood. The cause of the glove tear could only be identified in 81 incidents (33 percent). Ninety-two percent of the glove tears occurred when personnel were wearing one glove; 67 percent of the sharp injuries were caused by needle sticks, usually during suture placement. The majority of the sharp injuries (57 percent) occurred with injured the hand stationary or holding an object (11 percent); while the hand was retracting tissue (12 percent); and by instruments not in use (17 percent). These findings suggest that most glove tears are the result of unknown causes; however, changes in gloves or the number of gloves worn may reduce risk. Knowing the mechanism of sharp injuries should lead to the development of effective preventive strategies aimed at protecting operating room personal from exposure to blood-borne pathogens. (Consumer Summary produced by Reliance Medical Information, Inc.)

Author: Wright, James G., Ransohoff, David F., McGeer, Allison J., Chyatte, Douglas
Publisher: American Medical Association
Publication Name: JAMA, The Journal of the American Medical Association
Subject: Health
ISSN: 0098-7484
Year: 1991
Health aspects, Research, Evaluation, Injuries, Occupational health and safety, Occupational safety and health, Prevention, HIV infection, HIV infections, HIV (Viruses), HIV, Disease transmission, Rubber gloves, Gloves (Surgery), Nosocomial infections, Cross infection, Blood-borne diseases, Bloodborne diseases, Operating room personnel

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Gastroenterology

Article Abstract:

The association of Helicobacter pylori (H. pylori) bacteria with duodenal ulcers, improved mortality rates with colon cancer screening, projected advances in the molecular detection of cancers and the increasing use of laparoscopic cholecystectomy for treatment of gallstones are covered in a brief discussion of recent gastroenterological studies. H. pylori is present in the gastrointestinal tract of about 50% of adults in the US. Treatment to eradicate the organism has been shown to reduce the frequency of ulcer recurrence. The mortality rate from colon cancer was reduced by 70% in a 1992 study of sigmoidoscopic screening. Advances in the field of molecular biology may soon allow practitioners to identify a molecular marker associated with increased risks of colon cancer. Laparoscopic cholecystectomy is a less invasive technique for removing gallstones than traditional open surgery. However, there is still no conclusive evidence that it is safer than the traditional approach.

Author: Ransohoff, David F.
Publisher: American Medical Association
Publication Name: JAMA, The Journal of the American Medical Association
Subject: Health
ISSN: 0098-7484
Year: 1993
Practice, Gastroenterology

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Why are cholecystectomy rates increasing?

Article Abstract:

The large increase in laparoscopic cholecystectomies prompts the question of whether this new procedure actually benefits patients or if their gallstones could be left untreated. Laparoscopic cholecystectomy is a minimally invasive procedure for removing the gallbladder. A 22% increase in the number of these operations was found among Medicare patients in Pennsylvania. Open cholecystectomy, a more invasive surgery, is used for patients with severe gallbladder disease. Complications from surgery, such as injury to the bile duct, can occur, so the decision to operate should be based on whether the gallstones are causing the symptoms. Pain from gallstones is intense but not frequent. Elective cholecystectomy should be offered after other possible reasons for the symptoms are eliminated.

Author: Ransohoff, David F., McSherry, Charles K.
Publisher: American Medical Association
Publication Name: JAMA, The Journal of the American Medical Association
Subject: Health
ISSN: 0098-7484
Year: 1995
Care and treatment, Editorial, Usage, Gallstones, Cholecystectomy

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA

Similar abstracts:
  • Abstracts: New mechanisms of bacterial resistance to antimicrobial agents. Staphylococcus aureus bacteremia -- consider the source
  • Abstracts: The interferons: mechanisms of action and clinical applications. Interferons: biochemistry and mechanisms of action
  • Abstracts: Advanced glycosylation end products in patients with diabetic nephropathy. Glomerular lesions and urinary albumin excretion in type I diabetes without overt proteinuria
  • Abstracts: Overlap syndrome and its implications in pregnancy. Case report. Raised maternal serum alpha-fetoprotein levels during pregnancy following treatment of an endodermal sinus tumor: case report
  • Abstracts: Resectable gastric carcinoma: an evaluation of preoperative and postoperative chemotherapy. part 2 A phase II trial of tamoxifen in hepatocellular carcinoma
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.